Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01906424 · ClinicalTrials.gov registry record · NA

Restoring Arm and Hand Function With Non-invasive Spinal Stimulation

A NA study of Spinal Cord Injury and Paralysis, sponsored by NeuroEnabling Technologies.

Completed
Registry status
NA
Development phase
7
Enrollment target
2
Study locations

NCT01906424 is a NA study of Spinal Cord Injury and Paralysis that has completed, run by NeuroEnabling Technologies. The registered enrollment target is 7 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01906424, a NA study of Spinal Cord Injury and Paralysis, has completed, sponsored by NeuroEnabling Technologies.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target
2
Study locations

Study Summary

This study is to determine if non-invasive electrical stimulation of the spinal cord can help improve hand and arm function in people with paralysis who suffered a cervical spinal cord injury.

Interventions

  • DEVICE Transcutaneous Electrical Spinal Cord Stimulation

Study Locations (2)

California

  • University of California Los Angeles - Los Angeles
  • Strides SCI Functional Fitness - San Juan Capistrano

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2016-04
Est. Completion 2016-12-31
Phase NA

Sponsor

NeuroEnabling Technologies

2 total trials

What the Registry Record Tells You About NCT01906424

The ClinicalTrials.gov registry entry for NCT01906424 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (92% lower). The listed sponsor is NeuroEnabling Technologies, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Electrical Spinal Cord Stimulation is the first listed.

NCT01906424 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01906424 about?

NCT01906424 is a clinical study titled "Restoring Arm and Hand Function With Non-invasive Spinal Stimulation". This study is to determine if non-invasive electrical stimulation of the spinal cord can help improve hand and arm function in people with paralysis who suffered a cervical spinal cord injury.

What is the current status of trial NCT01906424?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2016-04. Estimated completion is 2016-12-31.

What conditions does trial NCT01906424 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Paralysis.

What interventions are being tested in trial NCT01906424?

The interventions under investigation include: Transcutaneous Electrical Spinal Cord Stimulation (DEVICE).

Who is sponsoring clinical trial NCT01906424?

This trial is sponsored by NeuroEnabling Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01906424 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.